CanSino Biologics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 92.73% vs -47.85% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 200.22% vs -410.20% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "413.80",
          "val2": "214.70",
          "chgp": "92.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "69.80",
          "val2": "7.60",
          "chgp": "818.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.80",
          "val2": "8.10",
          "chgp": "-16.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.50",
          "val2": "3.30",
          "chgp": "278.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.70",
          "val2": "-45.60",
          "chgp": "200.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.60%",
          "val2": "-221.50%",
          "chgp": "25.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 28.45% vs 134.50% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 107.26% vs 80.86% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,148.90",
          "val2": "894.40",
          "chgp": "28.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "67.90",
          "val2": "-217.50",
          "chgp": "131.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "62.10",
          "val2": "65.20",
          "chgp": "-4.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-6.70",
          "chgp": "58.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.20",
          "val2": "-416.00",
          "chgp": "107.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-109.60%",
          "val2": "-502.20%",
          "chgp": "39.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

413.80

214.70

92.73%

Operating Profit (PBDIT) excl Other Income

69.80

7.60

818.42%

Interest

6.80

8.10

-16.05%

Exceptional Items

12.50

3.30

278.79%

Consolidate Net Profit

45.70

-45.60

200.22%

Operating Profit Margin (Excl OI)

32.60%

-221.50%

25.41%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 92.73% vs -47.85% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 200.22% vs -410.20% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,148.90

894.40

28.45%

Operating Profit (PBDIT) excl Other Income

67.90

-217.50

131.22%

Interest

62.10

65.20

-4.75%

Exceptional Items

-2.80

-6.70

58.21%

Consolidate Net Profit

30.20

-416.00

107.26%

Operating Profit Margin (Excl OI)

-109.60%

-502.20%

39.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 28.45% vs 134.50% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 107.26% vs 80.86% in Dec 2024

All Annual Results